A Randomized Pilot Study Comparing the Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

Trial Profile

A Randomized Pilot Study Comparing the Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Nadroparin calcium (Primary) ; Rivaroxaban (Primary)
  • Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
  • Focus Adverse reactions
  • Acronyms DARINA
  • Most Recent Events

    • 23 Jun 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database record.
    • 23 Jun 2012 Actual initiation date (5 Jun 2012) added as reported by European Clinical Trials Database record.
    • 23 Jun 2012 New source identified and integrated (European Clinical Trials Database record EudraCT2011-003556-39).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top